Effects of growth conditions on the barrier properties of a human skin equivalent

Pharmaceutical Research

Volumn 26, Issue 7, 2009, Pages 1689-1700

  Batheja, Priya ^a,b   Song, Yifan ^c   Wertz, Philip ^d   Michniak Kohn, Bozena ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

Clofibrate; Permeability; Reconstructed skin; Skin equivalents; Transdermal

Indexed keywords

ASCORBIC ACID; CAFFEINE; CLOFIBRATE; COLLAGEN; FATTY ACID DERIVATIVE; HYDROCORTISONE;

ARTICLE; CELL CULTURE; CELL LEVEL; CELL STRUCTURE; CONTROLLED STUDY; FIBROBLAST; HISTOPATHOLOGY; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; REPRODUCIBILITY; SKIN PERMEABILITY;

ANTICHOLESTEREMIC AGENTS; ASCORBIC ACID; CELLS, CULTURED; CLOFIBRATE; COLLAGEN TYPE I; FATTY ACIDS; HUMANS; KERATINOCYTES; LIPIDS; MODELS, BIOLOGICAL; PERMEABILITY; PHARMACEUTICAL PREPARATIONS; PPAR ALPHA; SKIN; SKIN, ARTIFICIAL; TISSUE ENGINEERING;

EID: 67349115999     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-009-9879-1     Document Type: Article

References (34)

1. R Panchagnula K Stemmer WA Ritschel 1997 Animal models for transdermal drug delivery Methods Find Exp Clin Pharmacol. 19 335 341
2. F Cilurzo P Minghetti C Sinico 2007 Newborn pig skin as model membrane in in vitro drug permeation studies: a technical note AAPS PharmSciTech. 8 E94 doi:10.1208/pt0804094
3. DM Supp ST Boyce 2005 Engineered skin substitutes: practices and potentials Clin Dermatol. 23 403 412 doi:10.1016/j.clindermatol.2004.07.023
4. PG Shakespeare 2005 The role of skin substitutes in the treatment of burn injuries Clin Dermatol. 23 413 418 doi:10.1016/j.clindermatol.2004.07.015
5. S MacNeil 2007 Progress and opportunities for tissue-engineered skin Nature 445 874 880 doi:10.1038/nature05664
6. M Ponec J Kempenaar 1995 Use of human skin recombinants as an in vitro model for testing the irritation potential of cutaneous irritants Skin Pharmacol. 8 49 59
7. T Welss DA Basketter KR Schroder 2004 In vitro skin irritation: facts and future. State of the art review of mechanisms and models Toxicol In Vitro 18 231 243 doi:10.1016/j.tiv.2003.09.009
8. F Netzlaff M Kaca U Bock E Haltner-Ukomadu P Meiers CM Lehr UF Schaefer 2007 Permeability of the reconstructed human epidermis model Episkin in comparison to various human skin preparations Eur J Pharm Biopharm. 66 127 134 doi:10.1016/j.ejpb.2006.08.012
9. F Dreher F Fouchard C Patouillet M Andrian JT Simonnet F Benech-Kieffer 2002 Comparison of cutaneous bioavailability of cosmetic preparations containing caffeine or alpha-tocopherol applied on human skin models or human skin ex vivo at finite doses Skin Pharmacol Appl Skin Physiol. 15 Suppl 1 40 58 doi:10.1159/000066680
10. MA Perkins R Osborne FR Rana A Ghassemi MK Robinson 1999 Comparison of in vitro and in vivo human skin responses to consumer products and ingredients with a range of irritancy potential Toxicol Sci. 48 218 229 doi:10.1093/toxsci/ 48.2.218
11. OECD. Test Guideline 431: In vitro skin corrosion: human skin model test. Adopted on 13th April 2004, Paris, France; 2004.
12. PW Wertz 1992 Epidermal lipids Semin Dermatol. 11 106 113
13. J Vicanova E Boelsma AM Mommaas JA Kempenaar B Forslind J Pallon 1998 Normalization of epidermal calcium distribution profile in reconstructed human epidermis is related to improvement of terminal differentiation and stratum corneum barrier formation J Invest Dermatol. 111 97 106 doi:10.1046/j.1523-1747. 1998.00251.x
14. M Ponec S Gibbs G Pilgram E Boelsma H Koerten J Bouwstra 2001 Barrier function in reconstructed epidermis and its resemblance to native human skin Skin Pharmacol Appl Skin Physiol. 14 Suppl 1 63 71 doi:10.1159/000056392
15. FP Schmook JG Meingassner A Billich 2001 Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption Int J Pharm. 215 51 56 doi:10.1016/S0378-5173(00)00665-7
16. SD Roy J Fujiki JS Fleitman 1993 Permeabilities of alkyl p-aminobenzoates through living skin equivalent and cadaver skin J Pharm Sci. 82 1266 1268 doi:10.1002/jps.2600821217
17. Song Y. Investigation of percutaneous penetration: skin barrier function and its modulation. A dissertation submitted to the Graduate School of Biomedical Sciences, University of Medicine and Dentistry of New Jersey; 2004.
18. ST Boyce ML Williams 1993 Lipid supplemented medium induces lamellar bodies and precursors of barrier lipids in cultured analogues of human skin J Invest Dermatol. 101 180 184 doi:10.1111/1523-1747.ep12363678
19. DA Godwin BB Michniak KE Creek 1997 Evaluation of transdermal penetration enhancers using a novel skin alternative J Pharm Sci. 86 1001 1005 doi:10.1021/js9700457
20. VH Mak MB Cumpstone AH Kennedy CS Harmon RH Guy RO Potts 1991 Barrier function of human keratinocyte cultures grown at the air-liquid interface J Invest Dermatol. 96 323 327 doi:10.1111/1523-1747.ep12465212
21. PW Wertz DC Swartzendruber KC Madison DT Downing 1987 Composition and morphology of epidermal cyst lipids J Invest Dermatol. 89 419 425 doi:10.1111/1523-1747.ep12471781
22. CS Chen RM Lavker U Rodeck B Risse PJ Jensen 1995 Use of a serum-free epidermal culture model to show deleterious effects of epidermal growth factor on morphogenesis and differentiation J Invest Dermatol. 104 107 112 doi:10.1111/1523-1747.ep12613595
23. M Ponec S Gibbs A Weerheim J Kempenaar A Mulder AM Mommaas 1997 Epidermal growth factor and temperature regulate keratinocyte differentiation Arch Dermatol Res. 289 317 326 doi:10.1007/s004030050198
24. Y Uchida M Behne D Quiec PM Elias WM Holleran 2001 Vitamin C stimulates sphingolipid production and markers of barrier formation in submerged human keratinocyte cultures J Invest Dermatol. 117 1307 1313 doi:10.1046/j.0022-202x. 2001.01555.x
25. M Ponec A Weerheim J Kempenaar A Mulder GS Gooris J Bouwstra 1997 The formation of competent barrier lipids in reconstructed human epidermis requires the presence of vitamin C J Invest Dermatol. 109 348 355 doi:10.1111/1523-1747. ep12336024
26. S Pasonen-Seppanen TM Suhonen M Kirjavainen E Suihko A Urtti M Miettinen 2001 Vitamin C enhances differentiation of a continuous keratinocyte cell line (REK) into epidermis with normal stratum corneum ultrastructure and functional permeability barrier Histochem Cell Biol. 116 287 297 doi:10.1007/s004180100312
27. M Rivier I Safonova P Lebrun CE Griffiths G Ailhaud S Michel 1998 Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes J Invest Dermatol. 111 1116 1121 doi:10.1046/j.1523-1747.1998.00439.x
28. MQ Man EH Choi M Schmuth D Crumrine Y Uchida PM Elias 2006 Basis for improved permeability barrier homeostasis induced by PPAR and LXR activators: liposensors stimulate lipid synthesis, lamellar body secretion, and post-secretory lipid processing J Invest Dermatol. 126 386 392 doi:10.1038/sj.jid.5700046
29. G Krey H Keller A Mahfoudi J Medin K Ozato C Dreyer 1993 Xenopus peroxisome proliferator activated receptors: genomic organization, response element recognition, heterodimer formation with retinoid X receptor and activation by fatty acids J Steroid Biochem Mol Biol. 47 65 73 doi:10.1016/0960-0760(93)90058-5
30. M Schafer-Korting U Bock A Gamer A Haberland E Haltner-Ukomadu M Kaca 2006 Reconstructed human epidermis for skin absorption testing: results of the German prevalidation study Altern Lab Anim. 34 283 294
31. S Schreiber A Mahmoud A Vuia MK Rubbelke E Schmidt M Schaller 2005 Reconstructed epidermis versus human and animal skin in skin absorption studies Toxicol In Vitro 19 813 822 doi:10.1016/j.tiv.2005.04.004
32. C Asbill N Kim A El-Kattan K Creek P Wertz B Michniak 2000 Evaluation of a human bio-engineered skin equivalent for drug permeation studies Pharm Res. 17 1092 1097 doi:10.1023/A:1026405712870
33. T Fredriksson 1964 Studies on the percutaneous absorption of parathion and paraoxon. VI. In vivo decomposition of paraoxon during the epidermal passage J Invest Dermatol. 42 37 40
34. WG Reifenrath GS Hawkins MS Kurtz 1991 Percutaneous penetration and skin retention of topically applied compounds: an in vitro-in vivo study J Pharm Sci. 80 526 532 doi:10.1002/jps.2600800605